close icon

Bristol-Myers: Elliott Wave Setup can Double the Price

Bristol-Myers Squibb is in the process of acquiring Celgene in a $74 billion dollar cash-and-stock deal including debt. The deal faced opposition from hedge funds Wellington Management and Starboard Value, but ultimately gained shareholder approval on April 12th.

Arbitrageurs, who aim to profit from the discrepancy between the market price and the deal closing price, seem to have shorted BMY stock as a hedge, in order to protect their returns. The stock is set to open at $45.64 today, down from $54.38 in early March. In reality, BMY stock has been under pressure since July 2016, when it reached an all-time high of $77.12 a share.

The acquisition is expected to close in Q3 2019. From then on, management will have to deal with shareholder dilution, debt reduction and the integration of Celgene into Bristol-Myers. Despite the high quality of Celgene’s business, risks for long-term BMY investors have increased significantly. A lot can go wrong, but the actual outcome – positive or negative – will remain unknown for some time.

Bristol-Myers, A Pattern Has Emerged

Fortunately, we can look at the situation from another angle. It looks like all the news around BMY stock in the last three years, all the earnings reports, drug successes and failures, analysts’ upgrades and downgrades led to the formation of a recognizable Elliott Wave pattern. Take a look at it on the daily price chart of Bristol-Myers Squibb below.

Bristol-Myers setting the stage for a 100% rally

The daily chart reveals that the entire decline from $77.12 can be seen as an A-B-C flat correction. Waves A and B are simple a-b-c zigzags, while wave C appears to be an ending diagonal.

Prior to this retracement, BMY stock was in an uptrend. According to the Wave theory, once a correction is over the larger trend resumes. If we apply this here, it makes sense to expect a bullish reversal as wave 5 of C is poised to complete the entire pattern soon.

Despite all the risks, the market seems ready to give the BMY-Celgene deal its vote of confidence. The anticipated rally is supposed to regain all the value lost since July 2016. If this count is correct, a revisit of $77 a share is quite possible. Once there, $90 will not be too far away.

Did you like this analysis? Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Avoiding the 54% Crash in Brookfield Partners

When we last wrote about Brookfield Partners, the stock was hovering around $44 a share. That was on July 27th, 2019. Back then we though the price can reach $50, but instead of celebrating, the bulls should be getting ready to leave. The reason for our skepticism wasn’t some special insight into the company’s operations…

Read More »

Alphabet Stock To $1700 and… Below?

Similarly to the market at large, Alphabet stock felt the tremors caused by the coronavirus panic. The Google parent’s share price fell from $1531 to $1009 between February 19th and March 23rd. One of the biggest and strongest companies in the world lost 34% of its value in a little over a month. However, thanks…

Read More »

Sidestepping the 55% Crash in Steel Dynamics Stock

It’s been a little over four months since we wrote about Steel Dynamics. On January 16th, the stock was hovering around $33 a share. The price was down 37% from its May 2018 peak at $52.10. Yet, despite the reduced price, we thought investors would be better off avoiding the name. Our bearish opinion was…

Read More »

Omnicom Bears Face Strong Fibonacci Support

Yesterday, we talked about Interpublic and how Elliott Wave analysis warned us about its stock’s collapse two years in advance. Today, we are going to focus on Omnicom, which looked vulnerable to us in March 2018, as well. Omnicom rose from $20.09 to $89.66 between March 2009 and December 2016. The stock took full advantage…

Read More »

Two Years Ahead of Interpublic ‘s 55% Collapse

Interpublic and Omnicom used to be the giants of the advertising world. In the old economy, their competitive advantages seemed indestructible. Then, the Internet revolution came along and Facebook and Google created a lot of problems. However, their stocks were still making new highs until two years ago. Interpublic stock, for instance, was hovering around…

Read More »

Nestle Set to Complete a Pattern it Started in 2003

Nestle S.A. is one of the largest companies in the world and the biggest food and drink producer by revenue. The company is headquartered in Switzerland and went public in 2001. The stock’s all-time low was reached in March 2003, when it fell to CHF 23.32 a share. Seventeen years later now, Nestle stock is…

Read More »

Bulls to Lift Mondi Stock to New Highs

We first wrote about Mondi plc, the paper and packaging company, almost a year ago. On May 5th, 2019, the stock was hovering above 1700 pence per share. Despite being down 25% from its all-time high already, we thought it was too early for investors to buy the dip. Our pessimism was based not on…

Read More »

More analyses